QuiVad

Home / Funds / Linden Advisors LP

Linden Advisors LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Aurubis AGGermany1.58%October 26, 2026
AlvotechSweden0.91%September 15, 2026
Basic-Fit N.V.Netherlands0.63%October 28, 2026

Follow by RSS

Get the moves on Linden Advisors LP by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

470 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
February 4, 2021Outokumpu OYJFinland0.52%
February 3, 2021Audax Renovables, S.A.Spain1.00%
January 29, 2021Recipharm ABSweden1.06%
January 27, 2021Audax Renovables, S.A.Spain0.99%
January 27, 2021VoltaliaFrance0.63%January 21, 2022
January 26, 2021Audax Renovables, S.A.Spain1.02%
January 25, 2021Morphosys AGGermany0.49%
January 21, 2021Recipharm ABSweden1.16%
January 21, 2021Audax Renovables, S.A.Spain0.99%
January 19, 2021Recipharm ABSweden1.23%
January 19, 2021Morphosys AGGermany0.50%
January 14, 2021Recipharm ABSweden1.39%
January 13, 2021Recipharm ABSweden1.43%
January 12, 2021Recipharm ABSweden1.50%
January 12, 2021Audax Renovables, S.A.Spain1.03%
January 12, 2021Morphosys AGGermany0.48%
January 11, 2021Audax Renovables, S.A.Spain0.91%
January 7, 2021Audax Renovables, S.A.Spain0.83%
January 7, 2021Morphosys AGGermany0.50%
January 6, 2021Audax Renovables, S.A.Spain0.79%
January 5, 2021Audax Renovables, S.A.Spain0.51%
December 21, 2020Recipharm ABSweden1.60%
December 21, 2020Morphosys AGGermany0.48%
December 17, 2020Recipharm ABSweden1.54%
December 16, 2020Recipharm ABSweden1.35%
December 15, 2020Recipharm ABSweden1.15%
December 15, 2020Morphosys AGGermany0.50%
December 14, 2020Recipharm ABSweden0.87%
December 7, 2020Recipharm ABSweden0.73%
December 3, 2020Recipharm ABSweden0.59%
December 2, 2020Recipharm ABSweden0.60%
December 1, 2020Recipharm ABSweden0.55%
July 30, 2020Pharming Group N.V.Netherlands1.05%
June 11, 2020Pharming Group N.V.Netherlands1.18%
April 30, 2020Pharming Group N.V.Netherlands1.26%
April 21, 2020Pharming Group N.V.Netherlands1.18%
March 5, 2020Pharming Group N.V.Netherlands1.26%
March 3, 2020Pharming Group N.V.Netherlands1.32%
March 2, 2020Pharming Group N.V.Netherlands1.26%
March 2, 2020SMCPFrance0.45%March 4, 2020
February 26, 2020Pharming Group N.V.Netherlands1.32%
February 26, 2020SMCPFrance0.68%March 4, 2020
February 25, 2020SMCPFrance0.71%March 4, 2020
January 27, 2020Pharming Group N.V.Netherlands1.43%
January 23, 2020Pharming Group N.V.Netherlands1.36%
January 21, 2020Pharming Group N.V.Netherlands1.05%
January 16, 2020Pharming Group N.V.Netherlands0.93%
January 15, 2020Pharming Group N.V.Netherlands0.86%
January 14, 2020Pharming Group N.V.Netherlands0.56%
December 10, 2019SMCPFrance0.62%March 4, 2020

Download 470 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Linden Advisors LP, data as at October 28, 2026, https://www.quivad.com/detenteur/linden-advisors-lp?page=4